Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice  by Schnermann, Jurgen & Briggs, Josephine P.
Tubuloglomerular feedback: mechanistic insights
from gene-manipulated mice
Jurgen Schnermann1 and Josephine P. Briggs2
1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA and 2Howard
Hughes Medical Institute, Chevy Chase, Maryland, USA
Tubuloglomerular feedback (TGF) describes a causal and
direct relationship between tubular NaCl concentration at the
end of the ascending limb of the loop of Henle and afferent
arteriolar tone. The use of genetically altered mice has led to
an expansion of our understanding of the mechanisms
underlying the functional coupling of epithelial, mesangial,
and vascular cells in TGF. Studies in mice with deletions of
the A or B isoform of NKCC2 (Na,K,2Cl cotransporter) and of
ROMK indicate that NaCl uptake is required for response
initiation. A role for transcellular salt transport is suggested
by the inhibitory effect of ouabain in mutant mice with an
ouabain-sensitive a1 Na,K-ATPase. No effect on TGF was
observed in NHE2- and H/K-ATPase-deficient mice. TGF
responses are abolished in A1 adenosine receptor-deficient
mice, and studies in mice with null mutations in NTPDase1 or
ecto-50-nucleotidase indicate that adenosine involved in TGF
is mainly derived from dephosphorylation of released ATP.
Angiotensin II is a required cofactor for the elicitation of TGF
responses, as AT1 receptor or angiotensin-converting
enzyme deficiencies reduce TGF responses, mostly by
reducing adenosine effectiveness. Overall, the evidence from
these studies in genetically altered mice indicates that
transcellular NaCl transport induces the generation of
adenosine that, in conjunction with angiotensin II, elicits
afferent arteriolar constriction.
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Changes in NaCl concentration in the tubular lumen near the
tubulovascular contact point at the distal end of the ascending
loop of Henle elicit adjustments in glomerular arteriolar
resistance, a phenomenon referred to as ‘tubuloglomerular
feedback’ (TGF).1 As increases in NaCl concentration cause
increases of afferent arteriolar resistance and a fall in
glomerular filtration rate (GFR), the system is constructed
as a negative feedback loop that serves to keep NaCl delivery
into the distal parts of the nephron within narrow boundaries.
The TGF response is complex, requiring coordinated func-
tional changes in the epithelial, mesangial, and smooth muscle
cells, and delineation of the cellular mechanisms responsible
for linking the NaCl input with the vascular end points has
been relatively slow. Micropuncture has proven to be the most
valuable tool in establishing the relationship between luminal
NaCl concentration and GFR or glomerular capillary pressure,
but this approach has major limitations in resolving the
intermediate steps in the transmission pathway. The use of
imaging and electrophysiological techniques in isolated
perfused tubule/glomerulus preparations has provided an
approach for the detailed study of the changes in epithelial
function that result from changes in luminal composition, but
the relationship between specific changes in epithelial function
and the glomerular arteriolar end point has been difficult to
study with these preparations.2,3
The use of gene-manipulated mice has generated a new
venue to further explore the mechanisms responsible for
TGF. As micropuncture can be relatively easily adapted to this
species, the effect of targeted deletions of gene products
potentially involved in TGF can be studied without some of
the uncertainties associated with pharmacological interven-
tions. In this review, we are focusing on two areas where
gene-manipulated mice have facilitated major progress in
understanding the mechanisms. Substantial experimental
evidence supports the notions that luminal NaCl concentra-
tion initiates TGF responses by changes in tubular NaCl
transport, and that the signal arising from changes in NaCl
transport is transmitted across the juxtaglomerular inter-
stitium by the generation of paracrine messengers. The
availability of animals with defined transport deficits and
with targeted deficiencies in the generation or action of
potential mediators has permitted new insights in both of
these areas of TGF function.
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NaCl TRANSPORT
Apical NaCl uptake: NKCC2
There is general agreement that the primary mechanism
mediating the transduction of luminal NaCl concentration
into a propagated signal across the juxtaglomerular inter-
stitium is activation of the Na,K,2Cl cotransporter, NKCC2,
in the apical membrane of macula densa (MD) cells. This
basic tenet rests on the observation that a number of loop
diuretics, including furosemide, bumetanide, piretanide,
ethacrynic acid, triflocin, or L-ozolinone,1,4 produce complete
TGF inhibition, and on the good quantitative agreement
between the inhibitor concentrations causing half-maximal
inhibition of transport and TGF.5 Furosemide also blocks
TGF responses during retrograde perfusion, indicating that
TGF inhibition does not depend upon a metabolic product of
the thick ascending limb (TAL) transmitted to the MD cells.6
The direct evidence of an NaCl transport-dependency of
renin secretion, the other end point of luminal NaCl
concentration changes, is not as strong but is nevertheless
highly suggestive.1 NKCC2 has been found to be expressed in
MD cells, and its inhibition causes cellular hyperpolarization
and reductions in cytosolic Na and Cl concentrations.2,3
The salt-losing phenotype of mice with deficiencies in the
proximal fluid transporters NHE3 or AQP1 is relatively mild
despite the fact that the reabsorption of a substantial amount
of filtered NaCl and water depends upon these transport
pathways.7,8 TGF-mediated reductions of GFR and filtered
NaCl have been observed in both sodium/hydrogen
exchanger (NHE3/) and Aquaporin 1 (AQP1/) mice,
and it has been surmised that reductions in filtered NaCl load
by TGF are a major reason for the ability of mice with
proximal transport defects to achieve Na balance.9 In contrast,
mice with complete inactivation of the NKCC2 gene display
the severe salt-losing phenotype of antenatal Bartter syn-
drome.10 Although TGF responses have not been directly
assessed in these mice, inactivation of TGF is suggested by the
apparent inability to respond to the elevated distal NaCl load
with a reduction in GFR. In mice heterozygous for the
NKCC2-null mutation, NKCC2 protein expression was found
to be normal, and mice were indistinguishable from wild
type.11 Further functional exploration of the consequences of
NKCC2 deficiency has become possible with the generation of
mice with targeted disruption of single NKCC2 isoforms.12,13
The existence of three different full-length variants of NKCC2,
first reported by Payne and Forbush14 in the rabbit kidney, has
been confirmed in all species studied.15–17 These isoforms,
called NKCC2B, NKCC2A, and NKCC2F, are derived from
differential splicing of the variable exon 4 of the Slc12a1 gene,
a short 96-bp exon that encodes for the second transmem-
brane domain and parts of the adjacent intracellular loop of
the transporter.14 NKCC2 isoform expression shows a distinct
distribution pattern with F found exclusively in the medullary
thick ascending limb, A in both the outer medulla and cortex,
and B in the cortex.15,17,18 MD cells of the mouse have been
found to express both the B- and A-isoforms of the
cotransporter.12 Marked differences in ion affinities have been
identified in in vitro heterologous expression studies in
Xenopus laevis oocytes: F was found to have much lower Naþ
and Cl affinities than the A or the B isoform.18 To create
NKCC2B- and NKCC2A-deficient mice, the alternate exons
4B or 4A were modified by the introduction of in-frame stop
codons resulting in the premature termination of translation.
Thus, these strains of isoform-specific knockout mice lack
both the full-length and the corresponding truncated NKCC2
isoforms.
In vivo microperfusion of loops of Henle showed that in
NKCC2B-deficient mice, Cl reabsorption was significantly
reduced at low flow rates,12 whereas the lack of NKCC2A
resulted in reduced Cl absorption at high perfusion rates.13
These in vivo data are in line with the notion that TAL
reabsorption at low NaCl concentrations relies on the activity
of the high Cl-affinity NKCC2B isoform, whereas NKCC2A
comes into play when higher salt concentrations are achieved
by high loop perfusion flow. Assessment of TGF responses
has confirmed that MD signaling function depends on the
successive engagement of NKCC2B and NKCC2A (Figure 1).
In the low flow range, NKCC2B-deficient mice were less
responsive than wild-type animals, whereas TGF responses of
NKCC2A/ mice were reduced at high flow rates. Thus, V1/2,
the flow rate causing half-maximum TGF responses,
increased from 6.5 nl min1 in mice expressing only NKCC2B
to 15.5 nl min1 in mice possessing only NKCC2A. These
data suggest that the successive activation of the high Cl-
affinity NKCC2B and the lower Cl-affinity NKCC2A is
responsible for the surprisingly wide range of NaCl
concentrations over which TGF operates.
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Figure 1 | Relationship between loop of Henle perfusion rate
and the percentage reduction of stop flow pressure (±s.e.m.),
an expression of TGF responsiveness, in mice lacking NKCC2B
(circles) or NKCC2A (dots). Dashed lines indicate position of V1/2,
the flow rates causing half-maximum reduction of stop flow
pressure (PSF). Data are redrawn from Verlander et al.
45 and
Rajendran et al.46
Kidney International (2008) 74, 418–426 419
J Schnermann and JP Briggs: TGF mechanisms in genetically altered mice r e v i e w
Apical NaCl uptake: ROMK
Whereas the inhibitory effect of luminal barium on TGF
responses was diminished by a pronounced direct vascular
constrictor action,19 the retrograde application of the Kþ
channel blocker U37883A caused an almost complete
inhibition of TGF responsiveness.20 This effect is mediated
by renal outer medullary potassium (ROMK) type Kþ
channels, as TGF responses were largely absent in mice with
targeted ROMK deletion.21 The finding of a significantly
reduced but not abolished TGF response has subsequently
been confirmed in mice in which selective breeding of
surviving animals has generated ROMK-deficient mice with
less compromised kidney function and reasonably well-
maintained blood pressure.22 As shown in Figure 2, the mean
TGF response of 11.3±1.2 mm Hg in wild-type mice was
reduced to 2.2±0.6 mm Hg in ROMK-deficient mice
(Po0.001). The observation that inhibition of NKCC2 and
ROMK has similar effects on TGF responses argues against a
specific ‘sensor’ function of the actual transport proteins,
suggesting instead a critical role of some consequence of MD
NaCl transport. As ambient distal Kþ concentrations near
the MD are close to the Kþ affinity of the cotransporter,
variations in luminal Kþ may regulate TGF response
magnitude.20
Apical NaCl uptake: Na/H exchanger
Detailed studies in the isolated perfused juxtaglomerular
apparatus (JGA) preparation of the rabbit have clearly
documented the existence of Na/H exchange activity in both
the apical and basolateral membranes of MD cells. Increases
in luminal NaCl concentration cause increased hydrogen
efflux and subsequent alkalinization of the MD cell cytosol.24
It has been estimated that about 20% of total Na entry may
be mediated by Na/H exchange. Immunocytochemical data
indicate that the exchanger isoform in the apical membrane
is NHE2, whereas NHE4 is the isoform of the basolateral
membrane.25 MD cells are thus distinct from TAL cells, where
NHE3 is the dominant variant of the exchanger.26 How Na/H
exchange in MD cells could affect TGF has been unclear. One
possibility is that the intracellular pH determines the
magnitude of the response by disinhibiting MD neuronal
nitric oxide synthase (nNOS) and thereby augmenting the
generation of NO. In fact, it has been reported that Na/H
exchange inhibition with amiloride augments TGF responses
by preventing cell alkalinization and thereby causing relative
inhibition of nNOS.27,28 In contrast to these observations in
the isolated JGA preparation, there is no in vivo evidence that
would support a major role of Na/H exchange activity in TGF
responsiveness. Micropuncture studies in NHE2-deficient
mice failed to show changes in TGF responses compared to
wild-type animals,29 and loop of Henle perfusion with
amiloride or N-(isopropyl)-amiloride (EIPA) did not elicit
measurable alterations of TGF response magnitude.4 Thus, a
major TGF-modulating role of Na/H exchange-dependent
variations of cytosolic pH in TAL or MD cells is not
supported by in vivo observations currently available. TGF
responses have also been found to be well maintained in
NHE3/ mice,7 and autoregulation of GFR and renal
blood flow was not altered in NHE3/ mice with
transgenic expression of NHE3 in the intestinal tract.30
Basolateral NaCl extrusion: Na,K-ATPase
Although an effect of apical transport inhibition on TGF is
generally accepted, there is still considerable uncertainty
about the subsequent steps in the juxtaglomerular signaling
cascade. One possibility is that one of the intracellular
consequences of NKCC2-dependent NaCl uptake is directly
coupled to the mediating step. Detailed and sophisticated
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Figure 2 | Maximum reductions of stop flow pressure (PSF) in ROMKþ /þ (left) and ROMK/ mice (right). Lines connect values
from individual tubules taken at saturating flow rate (30 nl min1) bracketed by two measurements of PSF at zero loop flow. Mice were
supplied by Tong Wang and Steve Hebert (Yale University, New Haven, CT, USA), and some of the characteristics of the new ROMK strain
have been previously published.23
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studies in the isolated perfused rabbit JGA have identified
depolarization, alkalinization, and various ionic composi-
tional changes as results of an increased NaCl uptake, and it is
therefore conceivable that one or more of these changes
trigger the signaling events directly.3,31
A second possibility is that signal propagation is the
consequence of transcellular NaCl transport, with apical
uptake being the first step in the sequence. Transcellular NaCl
transport across the renal tubular epithelium universally
requires the support of Na,K-ATPase-dependent energy
supply. Until recently, the available data about Na,K-ATPase
in the MD made the transcellular transport hypothesis look
less likely. First, cytochemical and immunological localization
studies32,33 suggested that the expression of Na,K-ATPase in
the basolateral membrane of MD cells was quite low. In
addition, a microenzymatic determination of Na,K-ATPase
activity in microdissected rabbit MD cells arrived at the
conclusion that the activity levels were about 50-fold lower
than those in neighboring TAL cells.34 However, the
interpretation of these studies failed to take into account
the important impact of basolateral membrane folding on
enzyme density. For example, in the enzyme activity studies,
Na,K-ATPase was normalized to unit of cell volume rather
than to membrane surface area, an approach that would
underestimate a membrane-bound molecule by the mem-
brane-folding factor. Although the basolateral membrane of
MD cells is typically non-folded, extensive infolding in the
neighboring TAL cells may increase its basolateral membrane
by a factor of 10–20.35 Thus, the difference in enzyme activity
per unit cell-surface area between MD and TAL cells may
actually be at least 10-fold less than assumed. Species-specific
differences may also play a role.25,36 Extensive studies in the
rat using a well-defined antibody against a1 Na,K-ATPase
and its colocalization with nNOS, an MD cell marker, have
clearly established a robust presence of the enzyme in the
basolateral membrane of MD cells.37,38 In addition, MD cells
also express the b1 subunit of the enzyme and a g subunit
that may be either ga or both ga and gb.37,39–41 Again, the
staining of MD cells appeared somewhat less intense than
that in neighboring TAL cells, no doubt because of the
absence of basolateral infoldings in MD cells. Pharmaco-
logical studies examining the effect of Na,K-ATPase inhibi-
tion on TGF were also inconclusive. In rats, Na,K-ATPase
inhibition by ouabain, administered by luminal or peritub-
ular microinfusion, did not elicit clear reductions of TGF
responses (own unpublished data). However, the a1 subunit
of Na,K-ATPase, by far the predominant isoform of the
enzyme in the kidney, is largely resistant to ouabain in rats
and mice. Mice homozygous for a complete a1 Na,K-ATPase-
null mutation are not viable, whereas heterozygotes are
essentially normal with respect to renal function.23
Recently, however, the ingenious utilization of the
possibilities of gene manipulation has brought important
new information, suggesting an important role of Na,K-
ATPase in supporting TGF.29 TGF responses were determined
in double-mutant mice in whom the normal ouabain-
resistance pattern was reversed with a1 Na,K-ATPase mutated
to be ouabain sensitive and a2 Na,K-ATPase to be ouabain
resistant.42,43 Single-mutant mice with the natively ouabain-
resistant a1 isoform and the mutated a2 isoform served as
controls. In double-mutant mice, the intravenous infusion of
ouabain caused inhibition of TGF, which increased over the
course of 1–2 h. No such effect was seen in the ouabain-
resistant control mice, indicating that the ouabain effect on
TGF was not due to inhibition of a glycoside-sensitive ATPase
other than Na,K-ATPase. Attenuation of TGF responses in
sensitive but not resistant mice was also seen with luminal
ouabain administration. Maintenance of normal constrictor
responses to direct A1 adenosine receptor (A1AR) activation
indicates that the effect of ouabain was not a reflection of a
general loss of vascular reactivity but that it occurred at an
earlier step in the signaling pathway. The implication that
TGF signaling is an energy-consuming process is fully in
accord with our earlier observations that ATP depletion by
inhibitors of the respiratory chain or oxidative phosphory-
lation interferes with TGF responsiveness (Briggs JP,
Schnermann J, abstract; Pflugers Arch 1981; 389(Suppl):
R40). MD cells have numerous mitochondria scattered
throughout all regions of the cell, including the basal part.
Presumably because of the absence of basolateral infoldings,
their membrane-associated alignment is less obvious than it
is in proximal convoluted tubule (PCT), TAL, or distal
convoluted tubule (DCT) cells, and the distribution of
mitochondria is more akin to that in principal and
intercalated collecting duct cells. It is worth noting that the
involvement of Na,K-ATPase in TGF provides an immediate
explanation for the inhibitory effect of furosemide. In
contrast to the effect of ouabain alone, ouabain in
combination with furosemide does not cause cell swelling
or membrane depolarization of TAL cells, indicating that as a
result of the low intracellular Na concentration, the Na pump
becomes non-functional in the presence of the loop
diuretic.44 Overall, studies exploring the relation between
NaCl transport and TGF responses indicate that afferent
arteriolar vasoconstriction is paralleled by increased epithelial
ATP utilization, and suggest a link between metabolic rate
and the vascular end point.
Na extrusion: H(Na)/K-ATPase
An alternative model for the regulation of intracellular NaCl
in MD cells has been suggested by the observations in the
isolated rabbit JGA that the luminal administration of
ouabain caused an elevation of intracellular Na and
prevented the recovery of intracellular Na from the elevated
levels resulting from high luminal NaCl.36 This observation
was linked to the presence of a colonic H/K-ATPase (HKa2)
in the apical membrane of MD cells based on immunocyto-
chemistry and the finding that an increase in luminal Kþ
caused partial recovery of the cytosolic pH from the
acidification resulting from luminal and basolateral NaCl
removal.36,45 The ability of H/K-ATPase to mediate active Na
extrusion has previously been demonstrated in the distal
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colon.46 Nevertheless, in recent studies in H/K-ATPase-deficient
mice, TGF responses were found to be normal, suggesting
either that H/K-ATPase and its cytosolic effects do not play a
major role in TGF or that H/K-ATPase in mouse is not
expressed in the cells activating the TGF pathway.29
A word of caution may be appropriate at this point. Aside
from anatomical plausibility, there is no direct proof that the
MD cells are in fact the cells responsible for the generation of
the signal causing afferent arteriolar vasomotor responses.
While retrograde in vivo microperfusion experiments and
perfusion of dissected JGA specimen clearly point to an effect
of a limited segment around the glomerulus, an influence of
TAL cells within an about 50 mm segment upstream or
downstream from the MD is entirely feasible. In fact, the
clear effect of the undisputed TAL proteins NKCC2 and
Na,K-ATPase and the lack of effect of the MD proteins H/K-
ATPase and NHE2 on TGF responses may be interpreted as
supporting this possibility. It is also worth recalling that
amphibian species have been shown to possess mammalian-
like TGF responses, although they lack cells with the typical
MD appearance.47,48
SIGNAL MEDIATION
Adenosine
Control of glomerular arteriolar tone by tubular NaCl
concentration is the result of changes in the concentration
of several paracrine mediators within the confines of the
juxtaglomerular interstitium. The nucleoside adenosine has
been suggested to exert metabolic control of renal blood flow
and GFR via TGF-mediated vasoconstriction.49,50 In fact, the
inhibition of A1ARs with receptor-specific antagonists largely
prevented TGF-induced reductions of single nephron glo-
merular filtration rate (SNGFR) and glomerular capillary
pressure in the rat.51 Definitive support for a critical role of
A1AR in TGF responsiveness came from two studies of TGF
in A1AR-deficient mice generated independently by two
laboratories.52,53 In both experimental series, TGF responses
were completely abolished in the A1AR-deficient mice,
indicating that adenosine, as the endogenous agonist of
A1AR, is required for TGF responses to occur. In contrast to
observations in wild-type animals, SNGFR measured in
proximal segments (with TGF interrupted) and in distal
segments (with TGF intact) was not different in A1AR/
mice, indicating that the tonic suppression of GFR by
ambient distal flows requires intact A1AR.54 Furthermore,
TGF-induced oscillations of proximal tubular pressure were
not observed in the A1AR-deficient mice.54 As autoregulation
of renal blood flow and GFR is mediated in part by TGF, one
of the consequences of A1AR deficiency may be a reduction
in autoregulatory efficiency. In fact, steady-state autoregula-
tion of renal blood flow and GFR in response to a lowering of
blood pressure was significantly impaired in A1AR-deficient
mice.55 In addition, the dynamic autoregulatory response of
A1AR-deficient mice to a step increase in blood pressure was
reduced by 50% in the time frame mediated by TGF, whereas
total autoregulation was reduced by about 30%.56
A direct vasoconstrictor action of adenosine has been
demonstrated in perfused isolated afferent arterioles of the
mouse, an effect that was not seen in vessels from A1AR-
deficient mice, thereby establishing the role of A1AR in the
action of adenosine.57,58 Adenosine induces vasoconstriction
in mouse afferent arterioles by Gi-dependent activation of
phospholipase C, release of Ca from intracellular stores, and
subsequent entry of Ca2þ through L-type Ca2þ chan-
nels.57,59 Consistent with the stable vasoconstriction elicited
by TGF, the constrictor effect of adenosine in isolated vessels
can be maintained for extended periods of time, indicating
the absence of rapid receptor desensitization.57 TGF-
mediated vasoconstriction by adenosine is noteworthy as,
in most vascular beds, adenosine causes vasorelaxation
through activation of Gs-coupled A2AR. In fact, the steady-
state effect of administration of exogenous adenosine in the
mouse kidney is vasodilatation due to an excess of the
vasodilating A2AR receptor class in the entire renal
vasculature. Thus, adenosine-induced vasoconstriction
requires activation of A1AR without simultaneous stimula-
tion of A2AR in other parts of the renal vasculature.60 This
requirement appears to be met by the generation of
adenosine in the confines of the juxtaglomerular interstitium
and its exclusive delivery to afferent arterioles in which A1AR
expression dominates.
Angiotensin II has been shown to act as an important
cofactor of the constrictor actions of adenosine.58,61–63
Studies in mice with deletions of the angiotensin II receptor
(AT1A) or of the angiotensin-converting enzyme have shown
that TGF responses are largely absent in these animals.64,65
Furthermore, the fall in glomerular capillary pressure caused
by the administration of the A1AR agonist cyclohexyl
adenosine (CHA) was markedly diminished in AT1A
receptor-deficient mice, suggesting that non-responsiveness
to adenosine may importantly contribute to the attenuation
of TGF in mice with a compromised renin–angiotensin
system.66 In mice with deletions of tissue-bound angiotensin-
converting enzyme, TGF responses were significantly re-
duced.67 This effect seems to be a result of the absence of
endothelial angiotensin-converting enzyme, as the selective
expression of angiotensin-converting enzyme in the proximal
tubule was unable to restore normal TGF responsiveness.68
The mechanism underlying the cooperation between A1AR
and angiotensin II receptors has remained unclear. One
possibility is that the activation of phospholipase C (PLC) by
Gbg subunits released in the course of A1AR-dependent Gi
activation is synergistically enhanced by the simultaneous
stimulation of Gq proteins. Alternatively, adenosine has been
shown to prevent angiotensin receptor desensitization by
enhancing the Ca sensitivity of myosin light-chain kinase.69
Enhanced TGF responses may also be the result of an
angiotensin II-induced reduction in the local levels of NO.70
This notion agrees with the demonstration that MD nNOS
expression is elevated in AT1 receptor-deficient mice.71
It has been proposed that adenosine is produced and
released by MD cells as a by-product of increased NaCl
422 Kidney International (2008) 74, 418–426
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transport and ATP utilization.49 Although this suggestion has
not been completely excluded, the available experimental
evidence suggests that a major part of the adenosine required
for local A1AR activation is derived from the dephospho-
rylation of the released ATP. In the perfused rabbit JGA,
an increase in luminal NaCl concentration has been shown
to cause a rise of cytosolic Ca2þ in biosensor cells positioned
near the basolateral membrane of MD cells.72 The inhibition
of this response by suramin suggests that it was elicited
by the activation of P2 receptors secondary to the release
of ATP.
A direct role of ATP as a vasoconstrictor in the TGF
signaling pathway may be possible, but the evidence for this is
currently not compelling. Mice with a deletion of the P2X1
receptor, which has previously been shown to be present in
afferent arterioles,73 have impaired autoregulation of afferent
arteriolar tone,74 but have largely normal TGF responses
(Figure 3). The mean maximum TGF responses of
7.6±1 mm Hg in wild-type mice (n¼ 18) and of
5.4±0.6 mm Hg in P2X1-deficient mice were not significantly
different (P¼ 0.073). As the autoregulation studies were
performed in juxtamedullary arterioles, whereas the TGF
evidence comes from superficial nephrons, regional differences
in P2X1 receptor function may be responsible for these
conflicting outcomes. Nevertheless, because of their rapid
desensitization, P2X1 receptors would appear unsuited as
mediators of a response that can last for extended time periods,
so the role of other P2 receptors needs to be further
investigated.
ATP appears more likely to act predominantly through
generation of adenosine in the JG interstitium by extra-
cellular breakdown by ecto-ATPases and nucleotidases. In
fact, mice with deletion of NTDPase1, an extracellular ATPase
with expression at the glomerular vascular pole,75 have
significantly reduced TGF responses (http://www.ncbi.nlm.
nih.gov/pubmed/18256308). As one would expect NTPDase1
deficiency to be associated with elevated ATP levels, this
finding may further argue against a direct role of ATP in TGF.
The inhibition of ecto-50-nucleotidase (CD73) with a-b-
methyleneadenosine 50-diphosphate had earlier been shown
to reduce the compensatory efficiency of TGF and the slope
of the TGF function.76 Two groups of investigators using
independently generated strains of ecto-50-nucleotidase/
CD73-deficient mice have reported significant attenuation
of TGF responses.77,78 Thus, the successive dephosphoryla-
tion from ATP or ADP to AMP by NTPDase1 and from AMP
to adenosine by ecto-50-nucleotidase appears to provide most
of the adenosine required for TGF responsiveness.
Nitric oxide
The high levels of expression of neuronal NOS in MD cells
has stimulated extensive investigations of the role of NO in
juxtaglomerular signaling.79,80 The luminal administration of
inhibitors of NOS enhances TGF responses to elevations
of loop of Henle flow rate.1 Nevertheless, the response of
glomerular capillary pressure to changes in perfusion rate was
found to be identical over the entire flow range in wild-type
and nNOS-deficient mice.81 In contrast, measurements of
SNGFR showed a markedly increased proximal–distal SNGFR
difference, due for the most part to a significantly lower
SNGFR in distal tubules of nNOS-deficient mice.81 Thus, these
data suggest that the chronic absence of a functional nNOS in
MD cells is associated with an enhanced vasoconstrictor tone in
the subnormal flow range, presumably a consequence of a
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Figure 3 | Maximum reductions of stop flow pressure (PSF) in wild-type mice (left) and in P2X1-deficient mice (right). Lines connect
values from individual tubules measured at saturating flow rate (30 nl min1) and bracketed by two measurements of PSF at zero loop
flow. Mice originally generated by R Evans (University of Leicester, UK) were supplied by E Inscho (Medical College of Georgia, Atlanta,
GA, USA).
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proportional enhancement of pre- and post-glomerular
resistances. As stimulation of NO generation by loop of Henle
flow has been shown to usually occur in the supranormal flow
range,1 it is conceivable that the reduced SNGFR in nNOS/
mice is an indirect rather than a direct effect of reduced NO
availability. Nevertheless, it is noteworthy that direct measure-
ments of NO concentrations in distal tubular fluid have shown
an association of total NO release with reduced rather than
enhanced NaCl transport.82 TGF responses have been found to
be absent in mice with concurrent deficiencies in nNOS and
A1AR, indicating that nNOS deficiency does not overcome the
lack of A1AR signaling (Figure 4). This observation reaffirms
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Figure 5 | Scheme of TGF operation as supported by evidence mostly derived from studies in gene-manipulated mice. Solid arrows
indicate positive/stimulatory and broken arrows negative/inhibitory relationships. The depiction of cellular components is not meant to be
complete, but to indicate those proteins for which a role in TGF is suggested by experimental evidence from gene-manipulated mice.
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the primacy of A1AR signaling and a modulating role of NO in
the TGF pathway.
CONCLUSION
Taken together, evidence from studies in genetically modified
mice has resulted in a fairly robust mechanistic framework of
TGF operation. The metabolic activation of epithelial cells
resulting from increased transcellular NaCl transport
mediated by NKCC2, ROMK, and Na,K-ATPase is coupled
to ATP release and extracellular adenosine formation; this, in
turn, leads to activation of A1AR and vasoconstriction
(Figure 5). Several other paracrine factors interact with this
pathway to set vascular sensitivity. As this scheme identifies a
considerable number of testable (and still untested) hypoth-
eses, we expect that the further utilization of gene-
manipulated mice will remain a useful strategy to enhance
the understanding of juxtaglomerular signaling mechanisms.
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